The process of acquiring contact lenses begins not with a full prescription purchase, but with the critical stage of trial lenses. Biofinity, manufactured by CooperVision, represents a significant milestone in silicone hydrogel technology, designed to offer a balance of breathability and comfort. When a consumer considers moving from spectacles to contact lenses, or switching brands, the trial phase serves as the essential bridge. This period allows for the empirical validation of a lens's physical fit, the accuracy of the prescription when translated from glasses to a lens that sits directly on the cornea, and the subjective assessment of comfort over a prolonged period.
The Biofinity range is specifically engineered for versatility, catering to myopic (short-sighted) and hyperopic (long-sighted) patients. Because every human eye possesses a unique curvature and tear-film chemistry, a "one size fits all" approach is impossible in ocular health. Trial lenses eliminate the financial and physical risk of purchasing a bulk supply of lenses that may not settle correctly on the eye or may cause discomfort. For the UK consumer, understanding the technical parameters and the fitting process for Biofinity trial lenses is the first step toward achieving a sustainable, comfortable visual correction routine.
The Engineering Behind Biofinity Technology
The effectiveness of a Biofinity trial lens is rooted in its material composition and architectural design. Unlike older generations of soft lenses, Biofinity utilise a sophisticated silicone hydrogel matrix.
Aquaform Comfort Science Technology At the core of the Biofinity experience is the Aquaform Comfort Science Technology. This is not a surface coating, which can wear off over the course of a month, but a material property integrated into the lens. This technology utilises special, long siloxane molecule chains to increase oxygen transmissibility. The real-world impact is a high flow of oxygen to the cornea, which is vital for maintaining the health of the eye and preventing hypoxia. For the wearer, this manifests as a lens that feels "natural" and prevents the eyes from feeling strained or suffocating throughout the day.
Aspherical Lens Design The lenses feature an aspherical design, which is a critical technical detail for those seeking high-definition vision. While spherical lenses have a constant curvature, aspherical lenses are designed to reduce spherical aberrations. This results in a sharper, more crisp visual experience, particularly in the peripheral vision. This is especially beneficial for users engaged in activities like driving or sports, where a wide, clear field of view is a safety requirement.
The Aberration Neutralising System Complementing the aspherical design is the Aberration Neutralising System. This system works to ensure that vision remains clear and consistent across different lighting conditions and angles. By neutralising distortions that can occur at the edges of the lens, Biofinity ensures that the visual acuity is not just high at the centre but consistent across the entire optical zone.
Biofinity Trial Lens Fitting and Parameters
The fitting process for Biofinity trial lenses is a rigorous clinical exercise. It is not merely about checking the power of the lens, but ensuring the physical geometry of the lens matches the geometry of the patient's eye.
Physical Specifications Biofinity lenses are designed with a standard base curve and diameter that provide a predictable and consistent fit.
| Parameter | Specification |
|---|---|
| Base Curve | 8.6mm |
| Diameter | 8.6mm |
The consistency of these measurements allows eye care professionals to have a high rate of first-fit success, reducing the need for multiple trial cycles. However, as noted in professional guidelines, different base curves and diameters can occasionally be available within the product line to satisfy specific ocular requirements.
Prescription Range and Coverage One of the most significant advantages of the Biofinity and Biofinity XR range is the breadth of the available sphere powers. This ensures that nearly every patient, regardless of the severity of their prescription, can find a suitable trial lens.
- Sphere Powers for Biofinity: Range from +15.00D to -20.00D.
- Myopic Range: -6.00 to -0.25DS (available in 0.25D steps).
- Hyperopic Low Range: +0.25 to +6.00DS (available in 0.25D steps).
- Hyperopic Mid Range: +6.50 to +8.00DS (available in 0.50D steps).
- Hyperopic High Range: +8.50 to +15.00DS (available in 0.50D steps).
This extensive range means that Biofinity can cover approximately 99.995% of all spherical prescriptions, effectively removing the barrier for patients with extremely high prescriptions who previously believed they were ineligible for soft contact lenses.
The Biofinity Toric Trial Process
For patients with astigmatism, the trial process becomes more complex. Biofinity Toric lenses are designed to correct this irregularity in the corneal shape, but they must be perfectly aligned on the eye to function.
Toric Trial Range The Biofinity Toric options provide a specific set of parameters to address astigmatism.
| Component | Available Range |
|---|---|
| Power (Low to Mid) | +6.00 to -6.00 in 0.25 increments |
| Power (High Plus) | +8.00 to +6.50 in 0.50 increments |
| Power (High Minus) | -6.50 to -10.00 in 0.50 increments |
| Cylinder | -0.75 / -1.25 / -1.75 / -2.25 |
| Axis | 10° to 180° in 10° increments |
The Four-Step Fitting Guideline To ensure the toric trial lens is successful, eye care professionals follow a strict protocol.
- Initial Selection: The professional starts with a new refraction and selects the trial lens power based on the spectacle-to-contact lens conversion table. The axis selected is the one closest to the spectacle axis.
- Settling Period: Once inserted, the lens must remain in the eye for 10 minutes. This is crucial because the lens needs time to settle and stabilise on the ocular surface before any evaluation can take place.
- Fitting Evaluation: The professional checks for three specific things: corneal coverage and centration, the movement of the lens when the patient blinks (specifically in primary or upgaze positions), and the toric lens marking to determine if the lens has rotated.
- Visual Acuity Assessment: A spherical over refraction is performed. If the vision improves, the sphere power is adjusted. However, if the lens is rotating, simply changing the power will not work; axis compensation is required.
Axis Compensation Methods When a toric lens rotates, the professional must adjust the axis for the next trial lens. They use two primary acronyms for this: - LARS: Left Add, Right Subtract. - CAAS: Clockwise Add, Anti-clockwise Subtract.
Biofinity Multifocal Trial Considerations
The Biofinity Multifocal range is designed for patients with presbyopia, a condition where the eye loses the ability to focus on near objects. While these are standard monthly lenses, they are sometimes considered for "off-label" use.
Off-Label Application in Children In some specialised clinical settings, Biofinity Multifocal lenses are trialled for myopia control in children. This is not the primary regulatory purpose of the lens, and CooperVision does not officially endorse it. However, clinical data has shown varying results. For instance, one randomised controlled trial indicated that the +2.50 D (centre-distance) design was effective and tolerated for slowing the progression of myopia in children. Conversely, trials with the +1.50 D design were found to be ineffective for this specific purpose.
Toric Multifocal Options For those who suffer from both presbyopia and astigmatism, a toric design is available. However, it is important to note that the efficacy of the toric multifocal design for myopia control in children has not been extensively studied.
Wear Schedule and Lifestyle Integration
A primary reason for selecting Biofinity trial lenses is to test the "flexible wearing time" promised by the manufacturer.
Monthly Replacement Cycle Biofinity are monthly replacement lenses. This means that a single lens is intended to be worn for 30 days before being discarded. This offers a convenient middle ground between daily disposables and long-term lenses.
Extended Wear Capabilities One of the most standout features of Biofinity is its suitability for overnight wear. Users can wear these lenses for up to 6 nights and 7 days continuously. This is made possible by the Aquaform Technology, which ensures the cornea continues to receive oxygen even while the eyelids are closed during sleep.
Ideal User Profiles The trial phase is used to determine if Biofinity is suitable for the following user types: - Frequent Travellers: People who find it cumbersome to remove lenses every night. - Active Individuals: Those who need a lens that stays in place during intense physical activity. - Sufferers of Dry Eye: Because the lenses are naturally wettable and do not require surface coatings, they are often a preferred choice for people who experience dryness. - High-Demand Visual Users: Those who require sharp peripheral vision for driving or sports.
Acquiring Biofinity Trial Lenses in the UK
There are two primary pathways for acquiring Biofinity lenses, and the trial phase is the gatekeeper for both.
Professional Fitting Pathway The recommended route is through an Eye Care Professional (ECP). The professional does not just provide the lens but performs the technical verification of the base curve and diameter. They ensure the prescription is current and that the lens parameters satisfy the physical requirements of the wearer's eye. Once the trial is successful, the user can reorder through the practitioner. Consumers are encouraged to ask their ECP about current rebate programmes offered by CooperVision to reduce the cost of long-term supply.
Online Purchasing Pathway For those who already possess a valid, current prescription, buying Biofinity online is a viable and often more cost-effective option. Various retailers monitor pricing to offer discounts on 6-pack bundles. However, the online route assumes that the trial phase has already been completed by a professional to ensure the health of the eye.
Environmental Impact and Corporate Responsibility
Beyond the clinical specifications, the choice of Biofinity involves a commitment to environmental sustainability. CooperVision has implemented a plastic neutrality initiative.
Plastic Bank Partnership For every Biofinity lens fitted, the manufacturer partners with Plastic Bank to fund the collection and processing of an equal amount of plastic. This is measured by weight. A "credit" represents the collection and conversion of one kilogram of plastic that would otherwise end up in waterways.
Scope of Plastic Neutrality This initiative is comprehensive and covers the entire Biofinity product family, including: - Biofinity Sphere. - Biofinity Energys. - Biofinity Toric. - Biofinity Multifocal. - Biofinity XR. - Biofinity XR Toric. - Biofinity Toric Multifocal.
Detailed Analysis of Biofinity Performance and Suitability
The decision to proceed from a trial lens to a full prescription of Biofinity is based on a combination of clinical data and subjective patient experience. When evaluating the results of a Biofinity trial, several factors must be weighed.
First, the oxygen transmissibility is a non-negotiable factor for long-term ocular health. The use of silicone hydrogel prevents the "clouding" of the cornea that can occur with low-oxygen lenses, ensuring the eyes remain clear and white. This is particularly evident in patients who trial the lenses for the full 6-night/7-day extended wear cycle.
Second, the fit success rate is remarkably high. The data suggests that approximately 87% of wearers agree that the fitting process is predictable and consistent. This reduces the "trial-and-error" period that can sometimes frustrate new contact lens wearers.
Third, the range of power is an industry leader. By combining the standard Biofinity and the Biofinity XR (Extended Range), the manufacturer provides correction for 99.9% of spherical prescriptions. This makes Biofinity a primary choice for patients who have been told by other providers that their prescription is "too high" for soft lenses.
Finally, the comfort levels are backed by significant wearer data. On average, 84% of users strongly or somewhat agree that the Aquaform technology provides incredible all-day comfort. Because the material is naturally wettable, it avoids the degradation that can happen to lenses with artificial coatings, meaning the comfort experienced on day 1 of the trial is likely to be the same comfort experienced on day 30 of the lens life.